No profile data available.
Danaher Corporation (DHR) is a healthcare company in the biological analysis equipment industry, based in Washington, United States, with about 58,000 full-time employees.
It reported revenue of $24.57 billion for fiscal year 2025, up 2.9% from fiscal year 2024, and net income of $3.61 billion. In Q2 2026 (the quarter ended June 30, 2026) revenue was $6.27 billion, up 5.5% from a year before. Its largest business segment, Diagnostics, brought in 40% of segment revenue in fiscal year 2025; All Other was the largest region with 49%. Its market capitalization was $154.52 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments.
Danaher reported $24.57 billion in revenue for fiscal year 2025, up 2.9% from $23.88 billion in fiscal year 2024. In Q2 2026 revenue was $6.27 billion.
Diagnostics, with $9.94 billion or 40% of segment revenue in fiscal year 2025. Next: Life Sciences Excl. Biotechnology (30%) and Biotechnology (30%).
All Other: 49% of revenue by region in fiscal year 2025, followed by United States (41%).
$154.52 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (biological analysis equipment) include Agilent Technologies, Inc. (A), Illumina, Inc. (ILMN), Mettler-Toledo International Inc. (MTD), Revvity, Inc. (RVTY).